Gepants
Calcitonin gene-related peptide (CGRP) was suggested to play an important role in primary headaches as far back as 1985 and has been confirmed as playing a significant role in migraine pathophysiology. CGRP receptor antagonists are becoming more and more important for treatment of acute migraine attacks and for prophylaxis of episodic and chronic migraine. The development of drugs that bind CGRP o